Filing Details
- Accession Number:
- 0001127602-21-013891
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-16 16:35:22
- Reporting Period:
- 2021-04-15
- Accepted Time:
- 2021-04-16 16:35:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1730048 | C. Craig Hopkinson | 852 Winter St. Waltham MA 02451 | Evp R&D, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-04-15 | 28,920 | $19.72 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.32 to $19.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
